Literature DB >> 12475581

Diphenhydramine and hyaluronic acid derivatives reduce adnexal adhesions and prevent tubal obstructions in rats.

Ayse Filiz Avsar1, Fatih Mehmet Avsar, Mustafa Sahin, Serdar Topaloglu, Husamettin Vatansev, Metin Belviranli.   

Abstract

OBJECTIVE: The purpose of this study is to investigate the effects of diphenhydramine-HCl and Na-hyaluronate derivatives on the development of postoperative peritoneal adhesion and tubal obstruction. STUDY
DESIGN: Forty female rats of Sprague-Dawley type were used in the study. The rats were divided into four groups, each comprising 10 subjects. After all the rats were anaesthetized with 50mg/kg ketamine HCl, their abdomens were opened with a lower midline incision. Injury was induced on the right pelvic peritoneum and on the peritoneal surface of left uterine tube. No additional procedure was applied to the first group. 10 mg/kg diphenhydramine-HCl was given to the second group intravenously. In the third group, 0.25 mg/kg Orthovisc, a Na-hyaluronate derivative was diluted with 2 ml physiological saline and poured into the abdomen. For the fourth group, Seprafilm, a Na-hyaluronate derivative was covered in a layer of 0.7 cm x 3 cm over the left uterine tube. After 14 days, the rats were anaesthetized with ketamine HCl again, and 5 cm(3) blood sample was taken with cardiac puncture. The abdomen was opened with an incision transverse to the upper end of the midline incision, and the presence of adhesions was investigated. Detected adhesions were staged according to the Mazuji classification. Tubal patencies were inspected by injecting methylene blue from the uterine corpus into the lumen using an injector. A piece of abdominal wall of 4 cm x 4 cm was removed by extending the incision in the reverse U shape. The tensile strength and bursting pressure of the suture line were determined using the Peacock method. One gram of tissue was taken from the incision line, and hydroxyproline levels were determined by the Bergman-Loxley method. Aspartate aminotransferase (AST) levels were measured.
RESULTS: All of the rats completed the study. AST levels, tissue hydroxyproline levels and tensile strength and bursting pressure test results were found to be similar in all groups. While adhesion rates in the groups were 100, 40, 40 and 30%, respectively, adhesion stages were found to be, respectively as 2.1+/-1.7, 0.6+/-0.67, 0.6+/-0.67 and 0.5+/-0.85. Adhesion stages in the study groups were significantly lower (P<0.05). Tubal obstruction rates were found to be 70, 30, 30 and 20%, respectively.
CONCLUSION: Diphenhydramine, Orthovisc and Seprafilm significantly reduce postoperative peritoneal adhesion development, and they allow the uterine tubes to remain open.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12475581     DOI: 10.1016/s0301-2115(02)00213-0

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Reduction of postsurgical adhesions in a rat model: a comparative study.

Authors:  Oktay Irkorucu; Zafer Ferahköşe; Leyla Memiş; Ozgür Ekinci; Murat Akin
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

2.  Effect of Hypericum perforatum on intraperitoneal adhesion formation in rats.

Authors:  Deniz Hızlı; Fatih Hızlı; Aydın Köşüş; Saynur Yılmaz; Nermin Köşüş; Hacer Haltaş; Hülya Dede; Hasan Kafalı
Journal:  Arch Med Sci       Date:  2013-02-18       Impact factor: 3.318

3.  Seprafilm® adhesion barrier: (1) a review of preclinical, animal, and human investigational studies.

Authors:  Michael P Diamond; Ellen L Burns; Beverly Accomando; Sadiqa Mian; Lena Holmdahl
Journal:  Gynecol Surg       Date:  2012-04-20

4.  Intraperitoneal Triamcinolone Reduces Postoperative Adhesions, Possibly through Alteration of Mitochondrial Function.

Authors:  Neeraja Purandare; Katherine J Kramer; Paige Minchella; Sarah Ottum; Christopher Walker; Jessica Rausch; Conrad R Chao; Lawrence I Grossman; Siddhesh Aras; Maurice-Andre Recanati
Journal:  J Clin Med       Date:  2022-01-07       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.